Significance of HPV tests on women with cervical smears showing ASCUS

Acta Obstetricia et Gynecologica Scandinavica

Volumn 84, Issue 10, 2005, Pages 1001-1005

  De Lang, Anna ^a   Wikström, Ingrid ^b   Wilander, Erik ^a  

^a Department of Clinical Cytology ^*  (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ASCUS; Cytology; HPV; Hybrid capture II; PCR

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SQUAMOUS CELL; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS;

ADULT; AGE DISTRIBUTION; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA PROBES, HPV; DNA, VIRAL; FEMALE; HEALTH POLICY; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; SWEDEN; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 25844470325     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0001-6349.2005.00825.x     Document Type: Article

References (25)

1. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality of 25 cancers in 1990. Int J Cancer 1999; 83: 18-29.
2. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV et al. Human papillomavirus is a necessary cause of cervical cancer worldwide. J Pathol 1999; 189: 12-9.
3. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 244-65.
4. Vizcaino AP, Moreno V, Bosch FX, Munoz N, Barros-Dios XM, Borras J et al. International trends in incidence of cervical cancer: II Squamos-cell carcinoma. Int J Cancer 2000; 86: 429-35.
5. Pontén J, Adami HO, Bergstrom R, Dillner J, Friberg LG, Gustafsson L et al. Strategies for global control of cervical cancer. Int J Cancer 1995; 60: 1-26.
6. Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD et al. Accuracy of the Papanicolau test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 2000; 132: 810-9.
7. Sasieni PD, Cuzick J, Lynch-Framery E. Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. Br J Cancer 1996; 73: 1001-5.
8. Ho GY, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995; 87: 1365-71.
9. Nobbenhuis MA, Walboomers JM, Heimerhorst TJ, Rozendaal L, Remmink AJ, Risse EK et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 1999; 354: 20-5.
10. Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001; 93: 293-9.
11. Little J. Human papillomavirus testing. Effectiveness of testing for high risk HPV for triage of low grade abnormal smears is being assessed in TOMBOLA trial. BMJ 2001; 323: 109.
12. Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM et al. Evaluation of Human papillomavirus testing in primary screening for cervical abnormalities. Comparison of sensitivity, specificity and frequency of referral. JAMA 2002; 288: 1749-57.
13. Crabtree D, Unkraut A, Cozens D, Smith T, Lucas C, Pennington D et al. Role for HPV testing in ASCUS. A cytologic-histologic correlation. Diagn Cytopathol 2002; 27: 382-6.
14. Ho L, Terry G, Londesborough P, Cuzick J, Lorenzato F, Singer A. Human papillomavirus DNA detection in the management of women with twice mildly abnormal cytological smears. J Med Virol 2003; 69: 118-21.
15. Hansson BG, Forslund O, Bjerre B, Lindholm K, Nordenfeit E. Human papillomavirus types in routine cytological screening and at colposcopic examinations. Eur J Obstet Gynecol Reprod Biol 1993; 52: 49-55.
16. Gross GE, Barasso R (eds). Human papilloma virus. A clinical atlas. Berlin/Wiesbaden: Ullstein mosby GmbH and Co KG, 1997.
17. Jacobs MV, Walboomers JM, Snijders PJ, Voorhorst FJ, Verheijen RH, Fransen-Daalmeijer N et al. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int J Cancer 2000; 87: 221-7.
18. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338: 423-8.
19. Evander M, Edlund K, Gustafsson A, Jonsson M, Karlsson R, Rylander E et al. Human papillomavirus infection is transient in young women: a population-based cohort study. J Infect Dis 1995; 171: 1026-30.
20. Elfgren K, Kalantari M, Moberger B, Hagmar B, Dillner J. A population-based five-year follow-up study of cervical human papillomavirus infection. Am J Obstet Gynecol 2000; 183: 561-7.
21. Forslund O, Antonsson A, Edlund K, van den Brule AJ, Hansson BG, Meijer CJ et al. Population-based type-specific prevalence of high-risk human papillomavirus infection in middle-aged Swedish women. J Med Virol 2002; 66: 535-41
22. (Erratum in J Med Virol 2002; 67(3): 467).
23. Nonogaki S, Wakamatsu A, Longatto Filho A, Pereira SM, Utagawa ML, Ferreira Alves VA et al. Hybrid capture II and polymerase chain reaction for identifying HPV infections in samples collected in a new collection medium: a comparison. Acta Cytol 2004; 48: 514-20.
24. Bozetti M, Nonnenmacher B, Mielzinska II, Villa L, Lorincz A, Breitenbach VV et al. Comparison between hybrid capture II and polymerase chain reaction results among women at low risk for cervical cancer. Ann Epidemiol 2000; 10: 466.
25. Clavel C, Masure M, Bory JP, Putaud I, Mangeonjean C, Lorenzato M et al. Hybrid Capture Il-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 5118 women. Br J Cancer 1999; 80: 1306-11.